Cystic Fibrosis microbioom-bepaald antibioticatherapieonderzoek bij exacerbaties: resultaten gestratificeerd. KU Leuven
Antimicrobial resistance is arguably the most significant challenge facing the EU health care system. The unnecessary use of antibiotics is a key driver in the development of antibiotic resistance. Cystic Fibrosis (CF) represents a unique disease model to study bacterial resistance and to explore therapeutic strategies for same, as chronic lung infection overlaps with acute lung exacerbations caused by a multitude of organisms that ...